![]() Including scaly, erythematous patches, although each condition does have its unique features. ![]() Fungal infections and atopic dermatitis, the two most common skin conditions seen by pediatricians, share many similarities, To refrain from using high-potency steroids, such as C-BMV, in pediatric cases as there are more appropriate, safer alternativesĪpproximately 25% of patients seen by primary care physicians present with a primary or secondary skin complaint. In inappropriate settings, such as diaper dermatitis, regardless of their knowledge of the agent's potency. Of previous studies that used representative national data to assess the use of C-BMV. These self-reported data confirm and complement the findings There is no significant associationīetween knowledge of C-BMV potency and frequency of use (p>.1). ![]() Onlyġ8% of prescribing pediatricians correctly identify "Lotrisone" as a high potency steroid. 11% of C-BMV prescriptions exceed the recommended duration of therapy. Of pediatricians who prescribeĬ-BMV, 23% prescribe it for diaper dermatitis. With at least two years post-residency, who attended the 1999 American Academy of Pediatrics. The following evaluates the use of this combination based upon a survey of 106 US-based pediatricians The product is frequently used inappropriately in intertriginous areas, Fleischer, Jr.ĭepartment of Dermatology, Wake Forest University School of Medicinea AbstractĬlotrimazole-betamethasone diproprionate (C-BMV) is a fluorinated, high potency topical steroid that has been formulated withĬlotrimazole in the brand-named product, Lotrisone. Regardless of their Knowledge of the Drug's Potencyĭivya Railan, Jill K. Pediatricians who Prescribe Clotrimazole-Betamethasone Diproprionate (Lotrisone) often Utilize it in Inappropriate Settings
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |